GUJTHEM / NSE / Biotechnology & Drugs
Gujarat Themis Biosyn
1Y Price Trend
Key Information
Recommendations
Target High479.45
Target Low225.75
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk63.61
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Gujarat Themis Biosyn Ltd Hits Intraday Low Amid Price Pressure Markets Mojo
Gujarat Themis Biosyn board to meet on June 6 to consider fund raising scanx.trade
Gujarat Themis Biosyn Ltd Downgraded to Sell Amid Technical and Financial Concerns Markets Mojo
Gujarat Themis Biosyn’s Rs 3,000 crore bet: Can it build a global pharma platform? The Indian Express
Gujarat Themis Biosyn Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals Markets Mojo
Gujarat Themis Biosyn's (NSE:GUJTHEM) Anemic Earnings Might Be Worse Than You Think simplywall.st
Gujarat Themis Biosyn incorporates wholly owned subsidiary in Ireland scanx.trade
Gujarat Themis Biosyn Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026